However, in NSABP C-08, prognostic markers are being evaluated retrospectively to provide more insight into stage II colon cancer. The need for appropriate risk assessment has influenced clinical ...

The treatment of stage II colon cancer is a controversial issue that has persisted for the past decade. Clinicians must understand that accurate assessment of risk factors is the key to ...

A single mother from Houston, Texas, is sounding the alarm after dismissing early warning signs of colorectal cancer. In a ...

Karine Jean-Pierre shared about her personal life following the end of her tenure. The ex-White House press secretary wants ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

More frequent follow-up after curative surgery did not significantly reduce 10-year mortality rates in patients with stage II ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, shared clinical validation ...